The team at Roswell Park Comprehensive Cancer Center has reached record levels, growing to a workforce of more than 3,500. The latest appointments announced by Roswell Park President and CEO Candace S. Johnson, PhD, and her senior leadership team mark a milestone for the 121-year-old cancer center, reflecting expansion across all areas of operations, from clinical care and education to new frontie... »
The HER2 protein, which encourages the growth of cancer cells, is present in about 20% of all breast cancers. While HER2-positive breast cancers tend to be very aggressive, today the prognosis is generally very good, thanks to the introduction of HER2 inhibitors such as trastuzumab (brand name Herceptin). However, not all HER2-positive breast cancers respond to existing HER2 inhibitors. A renderin... »
Comprehensive cancer center has been recognized for superior performance five consecutive times BMT team earned distinction for adult and pediatric blood/marrow transplants FACT accreditation recognizes excellence in all areas of cellular therapy Roswell Park also designated as Blue Distinction® Center for Transplants BUFFALO, N.Y. — The blood and marrow transplant (BMT) program at Roswell Park Co... »
